Stay updated on Nivolumab and Relatlimab in MMRd Cancers Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Relatlimab in MMRd Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Relatlimab in MMRd Cancers Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    New help sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and a recruitment note states No longer looking for participants. The Intervention/Treatment heading formatting was adjusted and the revision updated to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-12T23:44:58.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.4 to v3.5.5, indicating a minor behind-the-scenes update to the page template or system release.
    Difference
    0.1%
    Check dated 2026-06-05T22:04:54.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.4, replacing the previous v3.5.3, indicating a deployment update to the ClinicalTrials.gov page.
    Difference
    0.1%
    Check dated 2026-05-15T15:19:09.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page revision label was updated from v3.5.2 to v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-24T06:18:30.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:40:31.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    Study status updated to Active, not recruiting and enrollment set to 38, with revised study dates. Contact information for the study team has been updated.
    Difference
    1%
    Check dated 2026-03-19T05:29:06.000Z thumbnail image

Stay in the know with updates to Nivolumab and Relatlimab in MMRd Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Relatlimab in MMRd Cancers Clinical Trial page.